注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Galecto Inc是一家臨床階段的生物技術公司。該公司專注於開發旨在針對位於纖維化核心的生物過程並影響廣泛的纖維化和相關疾病(包括癌症)的療法。該公司最初的重點是開發galectin-3和賴氨酰氧化酶樣2(LOXL2)的小分子抑製劑。該公司正在開發GB0139,用於治療嚴重的肺纖維化疾病,例如特發性肺纖維化(IPF),這是一種危及生命的進行性肺纖維化疾病。該公司的候選產品組合還包括GB1211,一種選擇性口服半乳糖凝集素三抑製劑,正在開髮用於治療與非酒精性脂肪性肝炎(NASH)相關的纖維化以及GB2064,一種用於治療骨髓纖維化的LOXL2選擇性口服抑製劑,一種骨髓疾病,其中纖維化降低了形成血細胞的能力。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Hans T. Schambye | 57 | 2020 | Co-Founder, President, CEO & Director |
Carl S. Goldfischer | 64 | 2020 | Independent Chairman of the Board |
Chau Quang Khuong | 48 | 2015 | Independent Director |
Jayson Donald Alexander Dallas | 56 | 2020 | Independent Director |
Anne Prener | 66 | 2021 | Independent Director |
Mark Thursz | - | - | Member of Clinical Advisory Board – Liver Cirrhosis |
Stephen A. Harrison | - | - | Member of Clinical Advisory Board – Liver Cirrhosis |
Aaron Gerds | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Claire Harrison | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
William L. Redmond | - | - | Member of Clinical Advisory Board – Oncology |
Raajit Rampal | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Adam Mead | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Amit D. Munshi | 56 | 2020 | Independent Director |
Jonathan Fallowfield | - | - | Member of Clinical Advisory Board – Liver cirrhosis |
Roy Steven Herbst | 61 | - | Member of Clinical Advisory Board – Oncology |
Søren Møller | 57 | 2020 | Independent Director |
David Shapiro | 70 | 2020 | Independent Director |
John Mascarenhas | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Alexander Maximiliaan Marie Eggermont | - | - | Member of Clinical Advisory Board – Oncology |
Michael Charlton | - | - | Member of Clinical Advisory Board – Liver cirrhosis |
Federico Cappuzzo | - | - | Member of Clinical Advisory Board – Oncology |
Massimo Pinzani | - | - | Member of Clinical Advisory Board – Liver Cirrhosis |
Jasmohan Bajaj | - | - | Member of Clinical Advisory Board – Liver cirrhosis |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核